Standard InChI: InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8-,10-/m1/s1
Standard InChI Key: GCQYYIHYQMVWLT-YPLKXGEDSA-N
Associated Targets(Human)
CCRF-HSB-2 188 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MRC5 9203 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Mo 135 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
E6SM 1586 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
M21 1715 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HEp-2 3859 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HeLa 62764 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
Human alphaherpesvirus 1 11089 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human alphaherpesvirus 2 4932 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human alphaherpesvirus 3 4092 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NIH3T3 5395 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Vero 26788 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
BSC-1 357 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
E1 SM 3 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 349.14
Molecular Weight (Monoisotopic): 347.9957
AlogP: -1.49
#Rotatable Bonds: 3
Polar Surface Area: 124.78
Molecular Species: NEUTRAL
HBA: 7
HBD: 4
#RO5 Violations: 0
HBA (Lipinski): 8
HBD (Lipinski): 4
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.74
CX Basic pKa:
CX LogP: -1.40
CX LogD: -1.40
Aromatic Rings: 1
Heavy Atoms: 20
QED Weighted: 0.53
Np Likeness Score: 1.30
References
1.De Clercq E, Desgranges C, Herdewijn P, Sim IS, Jones AS, McLean MJ, Walker RT.. (1986) Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine., 29 (2):[PMID:3005566][10.1021/jm00152a008]
2.Onishi T, Mukai C, Nakagawa R, Sekiyama T, Aoki M, Suzuki K, Nakazawa H, Ono N, Ohmura Y, Iwayama S, Okunishi M, Tsuji T.. (2000) Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety., 43 (2):[PMID:10649983][10.1021/jm9904194]
3.Reefschläger J, Pein CD, Cech D.. (1988) Synthesis and biological activities of 4-O-(difluoromethyl)-5-substituted-uracil nucleoside analogues., 31 (2):[PMID:2828623][10.1021/jm00397a022]
4.Kitano K, Machida H, Miura S, Ohrui H.. (1999) Synthesis of novel 4'-C-methyl-pyrimidine nucleosides and their biological activities., 9 (6):[PMID:10206544][10.1016/s0960-894x(99)00090-6]